Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Nilotinib | HCID 644241 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | Nilotinib hydrobromide | HCID 56592675 | — |
Reaction Steps
Nilotinib base Form A (4.00 g, 7.55 mmol) was suspended in EtOH abs. (40 mL, 10V) at room temperature. The suspension was heated to 80° C. and stirred for 30 min. HBr (48% aq., 0.9 mL, 7.78 mmol, 1.03 eq) was added in one portion. The suspension was stirred for one hour at 80° C. then cooled to ambient temperature by removal of the heating source. The stirring was then continued for about 20 h. A yellow solid was isolated by filtering the suspension thereby providing Nilotinib HBr form VIII. The sample was analyzed by PXRD (ARL X-ray powder diffractometer model X'TRA-019).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08937082B2 |
|---|
| Source dataset | uspto-grants-2015_01 |
|---|
| ORD ID | ord-1fd6d6adc95642b5af4a573c563bcf25 |
|---|
| Source note | uspto-grants-2015_01 |
|---|